(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 0.98% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.4%.
Treace Medical Concepts's revenue in 2025 is $218,879,000.On average, 8 Wall Street analysts forecast TMCI's revenue for 2025 to be $13,773,298,660, with the lowest TMCI revenue forecast at $13,213,216,798, and the highest TMCI revenue forecast at $14,184,280,231. On average, 8 Wall Street analysts forecast TMCI's revenue for 2026 to be $13,910,292,517, with the lowest TMCI revenue forecast at $12,800,960,866, and the highest TMCI revenue forecast at $15,180,830,892.
In 2027, TMCI is forecast to generate $15,002,420,288 in revenue, with the lowest revenue forecast at $13,425,397,981 and the highest revenue forecast at $17,006,990,864.